Cyclofenil

This image is provided by the National Library of Medicine.

WikiDoc Resources for Cyclofenil
Articles
Most recent articles on Cyclofenil Most cited articles on Cyclofenil Review articles on Cyclofenil Articles on Cyclofenil in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cyclofenil Images of Cyclofenil Photos of Cyclofenil Podcasts & MP3s on Cyclofenil Videos on Cyclofenil
Evidence Based Medicine
Cochrane Collaboration on Cyclofenil Bandolier on Cyclofenil TRIP on Cyclofenil
Clinical Trials
Ongoing Trials on Cyclofenil at Clinical Trials.gov Trial results on Cyclofenil Clinical Trials on Cyclofenil at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cyclofenil NICE Guidance on Cyclofenil NHS PRODIGY Guidance FDA on Cyclofenil CDC on Cyclofenil
Books
Books on Cyclofenil
News
Cyclofenil in the news Be alerted to news on Cyclofenil News trends on Cyclofenil
Commentary
Blogs on Cyclofenil
Definitions
Definitions of Cyclofenil
Patient Resources / Community
Patient resources on Cyclofenil Discussion groups on Cyclofenil Patient Handouts on Cyclofenil Directions to Hospitals Treating Cyclofenil Risk calculators and risk factors for Cyclofenil
Healthcare Provider Resources
Symptoms of Cyclofenil Causes & Risk Factors for Cyclofenil Diagnostic studies for Cyclofenil Treatment of Cyclofenil
Continuing Medical Education (CME)
CME Programs on Cyclofenil
International
Cyclofenil en Espanol Cyclofenil en Francais
Business
Cyclofenil in the Marketplace Patents on Cyclofenil
Experimental / Informatics
List of terms related to Cyclofenil

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cyclofenil (INN, trade names Ondogyne, Sexovid, and others) is a selective estrogen receptor modulator.

It was investigated as a possible treatment for scleroderma in the 1980s, but was found to be ineffective. Later study of its efficacy in treating Raynaud's phenomenon in people with scleroderma also found no statistically significant benefit.